Polymorphisms in the endocannabinoid receptor 1 in relation to fat mass distribution.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  European Journal of Endocrinology

• Publication date

  2010-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1530/EJE-10-0192PMID 20587580
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adipose tissue distribution is different in type 2 diabetes.

  2009cited by this paper
• Variants in the CNR1 and the FAAH Genes and Adiposity Traits in the Community

  2009cited by this paper
• Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle

  2009cited by this paper
• Endocannabinoid receptor 1 gene variations increase risk for obesity and modulate body mass index in European populations.

  2008cited by this paper
• Femoral-gluteal subcutaneous and intermuscular adipose tissues have independent and opposing relationships with CVD risk.

  2008cited by this paper
• Assessing Body Composition With DXA and Bioimpedance: Effects of Obesity, Physical Activity, and Age

  2008cited by this paper
• Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study.

  2008cited by this paper
• Association between cannabinoid type-1 receptor polymorphism and body mass index in a southern Italian population

  2007cited by this paper
• Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men.

  2007cited by this paper
• Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association With Metabolic Risk Factors in the Framingham Heart Study

  2007cited by this paper
• Endocannabinoids and the control of energy balance.

  2007cited by this paper
• The G1422A variant of the cannabinoid receptor gene (CNR1) is associated with abdominal adiposity in obese men

  2007cited by this paper
• No evidence for an involvement of variants in the cannabinoid receptor gene (CNR1) in obesity in German children and adolescents.

  2007cited by this paper
• Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study.

  2006cited by this paper
• Prevalence of overweight, obesity and physical inactivity in 20- to 29-year-old, Danish men. Relation to sociodemography, physical dysfunction and low socioeconomic status: the Odense Androgen Study

  2006cited by this paper
• Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial.

  2006cited by this paper
• Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue.

  2005cited by this paper
• Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.

  2005cited by this paper
• Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia.

  2005cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors

  2002cited by this paper
• Leptin-regulated endocannabinoids are involved in maintaining food intake

  2001cited by this paper
• Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome.

  2000cited by this paper
• Practical statistics for medical research

  1990cited by this paper

• Sweet Taste Receptors’ Genetic Variability in Advanced Potential Targets of Obesity

  2025cites this paper
• The possible link between endocannabinoid system gene polymorphisms and overweight/obesity susceptibility in individuals living in the Marmara Region

  2025cites this paper
• Exploring the Therapeutic Potential of Cannabinoid Receptor Antagonists in Inflammation, Diabetes Mellitus, and Obesity

  2023cites this paper
• Targeting appetite and satiety in diabetes and obesity, via G protein-coupled receptors.

  2022cites this paper
• How Stress Can Change Our Deepest Preferences: Stress Habituation Explained Using the Free Energy Principle

  2022cites this paper
• Pharmacogenetics of new classes of antidiabetic drugs

  2021cites this paper
• On the Role of Central Type-1 Cannabinoid Receptor Gene Regulation in Food Intake and Eating Behaviors

  2021cites this paper
• What Role Does the Endocannabinoid System Play in the Pathogenesis of Obesity?

  2021cites this paper
• Growth hormone deficiency and other endocrinopathies after childhood brain tumors: results from a close follow-up in a cohort of 242 patients

  2021cites this paper
• G1359A Variant of the Cannabinoid Receptor Gene (rs1049353) and Obesity-Related Traits and Related Endophenotypes: A Meta-Analysis

  2018cites this paper
• Genetic polymorphisms of the endocannabinoid system in obesity and diabetes

  2018cites this paper
• Role of Endocannabinoids on Sweet Taste Perception, Food Preference, and Obesity-related Disorders

  2017cites this paper
• Brain structural and clinical changes after first episode psychosis: Focus on cannabinoid receptor 1 polymorphisms.

  2015cites this paper
• CYP1A2*1D and *1F Polymorphisms Have a Significant Impact on Olanzapine Serum Concentrations

  2015cites this paper
• Cannabinoid Receptor 1 Gene Polymorphisms and Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome and in Healthy Controls

  2014cites this paper
• The genetic influence on body fat distribution

  2013cites this paper
• Associations of variants of CNR1 with obesity and obesity-related traits in Chinese women.

  2012cites this paper
• CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia

  2012cites this paper
• Childhood Obesity and the Role of Dopamine D2 Receptor and Cannabinoid Receptor-1 Gene Polymorphisms

  2012influential citation
• Rola układu endokannabinoidowego i polimorfizmów genu CNR1 w powstawaniu otyłości

  2011cites this paper
• Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk

  2011cites this paper
• G1359A polymorphism in the cannabinoid receptor-1 gene is associated with coronary artery disease in the Chinese Han population.

  2011cites this paper
• Association of genetic variation in cannabinoid mechanisms and gastric motor functions and satiation in overweight and obesity

  2011cites this paper
• Endocannabinoids and obesity development – the adipose tissue

  2010cites this paper
• Are endocannabinoid type 1 receptor gene (CNR1) polymorphisms associated with obesity and metabolic syndrome in postmenopausal Polish women?

  2009cites this paper